(Q43031473)

12 November 2017

title

Risk of alanine aminotransferase flare-up among asymptomatic hepatitis C virus RNA carriers: a 10-year follow-up study (English)

1 reference

12 November 2017

1 reference

1 reference

Tsuji K

1

1 reference

12 November 2017

Yamasaki K

2

1 reference

12 November 2017

Yamanishi M

3

1 reference

12 November 2017

Kawakami M

4

1 reference

12 November 2017

Shirahama S

5

1 reference

12 November 2017

publication date

1 May 2001

1 reference

Journal of Gastroenterology and Hepatology

12 November 2017

published in

1 reference

12 November 2017

volume

16

1 reference

12 November 2017

issue

5

1 reference

12 November 2017

page(s)

536-540

1 reference

Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV.

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02474.X

Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02474.X

Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. The Hepatitis C Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02474.X

Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02474.X

Hepatitis C virus RNA in serum and liver histology in asymptomatic anti-HCV positive subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02474.X

A retrospective study of hepatitis C virus carriers in a local endemic town in Japan. A possible presence of asymptomatic carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02474.X

Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02474.X

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02474.X

Influence of different hepatitis C virus genotypes on the course of asymptomatic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02474.X

Development of human T-cell leukemia virus type 1-transformed tumors in rats following suppression of T-cell immunity by CD80 and CD86 blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02474.X

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02474.X

10.1046/J.1440-1746.2001.02474.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference